ENBIS-24 Conference

Session

Biostatistics

18 Sept 2024, 14:00

Leuven, Belgium

Conveners

Biostatistics

• Daniel Jeske (University of California, Riverside)

134. A New Interpretation To The Equivalence Test (TOST) By (Bayesian) Success Probabilities.

Bernard Francq (GSK)

18/09/2024, 14:00

In medical and pharma research, statistical significance is often based on confidence intervals (CIs) for means or mean difference and p-values, the reporting of which is included in publications in most top-level medical journals. However, recent years have seen ongoing debates on the usefulness of these inferential tools. Misinterpretations of CIs for means and p-values can lead to...

95. Statistics in practice, to handle a pandemic emergency.

Stefano Barone (University of Palermo)

18/09/2024, 14:20

The management of the COVID 19 pandemic, especially during years 2020 and 2021, highlighted a serious shortage at all levels and in the majority of countries around the world.
Some countries reacted slightly better, having faced similar epidemics in their recent past, but obviously this was not enough, since the flows of people worldwide are now so huge that it makes little sense to make...